Hepion pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Hepion pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 1.910 million compared to usd 3.852 million a year ago. net loss was usd 1.819 million compared to usd 157,058 a year ago. basic loss per share from continuing operations was usd 0.53 compared to usd 44.27 a year ago. for the nine months, operating loss was usd 5.527 million compared to usd 11.598 million a year ago. net loss was usd 4.824 million compared to usd 6.876 million a year ago. basic loss per share from continuing operations was usd 6.7 compared to usd 94.08 a year ago.
HEPA Ratings Summary
HEPA Quant Ranking